Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoko Nanri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Haematologica|September 3, 2010
Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemiaNorio Asou, Eisaku Iwanaga, Tomoko Nanri, et al.
International Journal of Oncology|November 27, 2010
Mutation in the RNA binding protein TIS11D/ZFP36L2 is associated with the pathogenesis of acute leukemiaEisaku Iwanaga, Tomoko Nanri, Hiroaki Mitsuya, et al.
Genes, Chromosomes & Cancer|December 3, 2009
A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutationTomoko Nanri, Naokuni Uike, Toshiro Kawakita, et al.
Haematologica|February 3, 2009
A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemiaEisaku Iwanaga, Tomoko Nanri, Naofumi Matsuno, et al.
European Journal of Haematology|July 24, 2009
Acute promyelocytic leukemia harboring a STAT5B-RARA fusion gene and a G596V missense mutation in the STAT5B SH2 domain of the STAT5B-RARAEisaku Iwanaga, Miki Nakamura, Tomoko Nanri, et al.
International Journal of Hematology|January 17, 2009
Micafungin-induced immune hemolysis attacksTomoko Nanri, Eisaku Iwanaga, Satomi Fujie, et al.
European Journal of Haematology|June 12, 2013
High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemiaKenji Tokunaga, Shunichiro Yamaguchi, Eisaku Iwanaga, et al.
European Journal of Haematology|January 22, 2014
IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutationShunichiro Yamaguchi, Eisaku Iwanaga, Kenji Tokunaga, et al.
Leukemia Research|March 10, 2005
p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemiaNaofumi Matsuno, Koyu Hoshino, Tomoko Nanri, et al.
Leukemia Research|August 13, 2010
Extramedullary tumors presenting double vision in patients with t(8;21)(q22;q22) acute myeloid leukemia lacking mutations in the receptor tyrosine kinase genes KIT or FLT3Takahiro Tsuji, Noritaka Takatsu, Kisato Nosaka, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Haematologica|September 3, 2010
Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemiaNorio Asou, Eisaku Iwanaga, Tomoko Nanri, et al.
International Journal of Oncology|November 27, 2010
Mutation in the RNA binding protein TIS11D/ZFP36L2 is associated with the pathogenesis of acute leukemiaEisaku Iwanaga, Tomoko Nanri, Hiroaki Mitsuya, et al.
Genes, Chromosomes & Cancer|December 3, 2009
A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutationTomoko Nanri, Naokuni Uike, Toshiro Kawakita, et al.
Haematologica|February 3, 2009
A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemiaEisaku Iwanaga, Tomoko Nanri, Naofumi Matsuno, et al.
European Journal of Haematology|July 24, 2009
Acute promyelocytic leukemia harboring a STAT5B-RARA fusion gene and a G596V missense mutation in the STAT5B SH2 domain of the STAT5B-RARAEisaku Iwanaga, Miki Nakamura, Tomoko Nanri, et al.
International Journal of Hematology|January 17, 2009
Micafungin-induced immune hemolysis attacksTomoko Nanri, Eisaku Iwanaga, Satomi Fujie, et al.
European Journal of Haematology|June 12, 2013
High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemiaKenji Tokunaga, Shunichiro Yamaguchi, Eisaku Iwanaga, et al.
European Journal of Haematology|January 22, 2014
IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutationShunichiro Yamaguchi, Eisaku Iwanaga, Kenji Tokunaga, et al.
Leukemia Research|March 10, 2005
p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemiaNaofumi Matsuno, Koyu Hoshino, Tomoko Nanri, et al.
Leukemia Research|August 13, 2010
Extramedullary tumors presenting double vision in patients with t(8;21)(q22;q22) acute myeloid leukemia lacking mutations in the receptor tyrosine kinase genes KIT or FLT3Takahiro Tsuji, Noritaka Takatsu, Kisato Nosaka, et al.
Pageof 1